Ann: Response to ASX Query, page-14

I can say that for sure QUT has benefited a lot by using Tissue Therapies and FTT for their scopes.
Thanks to benevolent shareholders the company has regularly paid high fees to the institution with the objective to finance the university R&D.
The rest has been outperformed by the easy access to the Australian grant system.

Well done QUT and to the company Board for having achieved and fulfilled until the last penny the university objectives.

GREAY, GREAT, GREAT and ALLELUIA